Shawn Nelson Jr.

Shawn Nelson Jr., Ph.D., currently serves as a Senior Scientist in Medicinal Chemistry at Monte Rosa Therapeutics, having joined in April 2024. Previously, Shawn held the position of Principal Scientist at Nido Biosciences from June 2022 to January 2024, and served in various roles at the Broad Institute of MIT and Harvard between October 2019 and May 2022, culminating as a Senior Research Scientist I. Earlier experience includes a Scientist role at Verseon and extensive research during graduate studies at Harvard University, where Shawn completed a Ph.D. in Chemistry. Additionally, Shawn has interned at Novartis and contributed to medicinal chemistry projects during undergraduate studies at Rensselaer Polytechnic Institute.